Amalgam - Resurrection and redemption. Part 2: The medical mythology of anti-amalgam

Quintessence International

Volumn 32, Issue 9, 2001, Pages 696-710

  Wahl, Michael J ^a  

^a NONE   (United States)

Author keywords

Amalgam; Biocompatibility; Mercury; Resin composite; Safety; Toxicity

Indexed keywords

DENTAL ALLOY; MERCURY; RESIN;

ANIMAL; ANTIBIOTIC RESISTANCE; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; DENTIST; DRUG EFFECT; FEMALE; HUMAN; IMMUNE SYSTEM; MENTAL DISEASE; OCCUPATIONAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; CHRONIC DISEASE; COMPOSITE RESINS; DENTAL AMALGAM; DENTAL STAFF; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; IMMUNE SYSTEM; KIDNEY FAILURE, CHRONIC; MENTAL DISORDERS; MERCURY; OCCUPATIONAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0035491827     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (170)

1. Simonsen RJ. Move over amalgam-At last. Quintessence Int 1995;26:157.
2. Christensen GJ. The death of amalgam is imminent...Are you ready? Dent Econ 1999;89(6):34.
3. Lutz FU, Krejci I, Oddera M. Advanced adhesive restorations: The post-amalgam age. Pract Periodont Aesthet Dent 1996;8:385-394.
4. Dickerson WG. Integrating cosmetic dentistry into a busy practice. Dent Econ 1997;87(1):30-36.
5. Dickerson WG. Why is esthetic dentistry grouped with the outlaws? Dent Econ 1998;88(12):42-46,105.
6. Maroon M. The fab five. Dent Leader 1998;Mar:2-3.
7. Lorscheider FL, Vimy MJ, Summers AO. Mercury exposure from "silver" tooth fillings: Emerging evidence questions a traditional dental paradigm. FASEB J 1998;9: 504-508.
8. Mjör IA. Biological side effects to materials used in dentistry. J R Coll Surg Edinb 1999;44:146-149.
9. Eley BM. The future of dental amalgam: A review of the literature. Part 6. Possible harmful effects of mercury from dental amalgam. Br Dent J 1997;182:455-459.
10. Eneström S, Hultman P. Does amalgam affect the immune system? A controversial issue. Int Arch Allergy Immunol 1995;106:180-203.
11. Dodes JE. The amalgam controversy: An evidence-based analysis. J Am Dent Assoc 2001;132:348-356.
12. Mackert JR. Dental amalgam and mercury. J Am Dent Assoc 1991;122(8):54-61.
13. Fung YK, Molvar MP. Toxicity of mercury from dental environment and from amalgam restorations. Clin Toxicol 1992;30:49-61.
14. Li Y, Siew C, Shearer BG, ADA Council on Scientific Affairs. Dental amalgam: Update on safety concerns. J Am Dent Assoc 1998;129:494-503.
15. Mackert JR, Berglund A. Mercury exposure from dental amalgam fillings: Absorbed dose and the potential for adverse health effects. Crit Rev Oral Biol Med 1997;8: 410-436.
16. Laine J, Konttinen YT, Beliaev N, Happonen R-P. Immunocompetent cells in amalgam-associated oral lichenoid contact lesions. J Oral Pathol Med 1999;28: 117-121.
17. Pleva J. Dental mercury-A public health hazard. Rev Environ Health 1994;10:1-27.
18. Hanson M, Pleva J. The dental amalgam issue. A review. Experientia 1991;47:9-22.
19. Wahl MJ. Amalgam-Resurrection and redemption. Part 1: The clinical and legal mythology of anti-amalgam. Quintessence Int 2001;32:525-535.
20. Osborne JW. Dental amalgam and mercury vapor release. Adv Dent Res 1992,6:135-138.
21. Berry TG, Summitt JB, Chung AKH, Osborne JW. Amalgam at the new millenium. J Am Dent Assoc 1998;129:1547-1556.
22. Gay DD, Cox RD, Reinhardt JW. Chewing releases mercury from fillings [letter]. Lancet 1979;1:985-986.
23. Abraham JE, Svare CW, Frank CW. The effect of dental amalgam restorations on blood mercury levels. J Dent Res 1984;63:71-73.
24. Patterson JE, Weissberg BG, Dennison PJ. Mercury in human breath from dental amalgams. Bull Environ Contam Toxicol 1985;34:459-468.
25. Evaluation of human health risks. Environmental Health Criteria 118. Inorganic Mercury. Geneva: World Health Organization, 1991:108-114.
26. Previous evaluations by international bodies. Environmental Health Criteria 118. Inorganic Mercury. Geneva: World Health Organization, 1991:116.
27. Vimy MJ, Lorscheider FL. Intra-oral air mercury released from dental amalgam. J Dent Res 1985;64:1069-1071.
28. Vimy MJ, Lorscheider FL. Serial measurements of intra-oral air mercury: Estimation of daily dose from dental amalgam. J Dent Res 1985;64:1072-1075.
29. Mackert JR. Factors affecting estimation of dental amalgam mercury exposure from measurements of mercury vapor levels in intra-oral and expired air. J Dent Res 1987;66:1775-1780.
30. Olsson S, Bergman M. [letter] Letter to the editor. J Dent Res 1987;66:1288-1289.
31. Berglund A, Pohl L, Olsson S, Bergman M. Determination of the rate of release of intra-oral mercury vapor from amalgam. J Dent Res 1988;67:1235-1242.
32. Olsson S, Bergman M. Daily dose calculations from measurements of intra-oral mercury vapor. J Dent Res 1992;71:414-423.
33. Berglund A. Estimation by a 24-hour study of the daily dose of intra-oral mercury vapor inhaled after release from dental amalgam. J Dent Res 1990;69:1646-1651.
34. Isacsson G, Barregård L, Seldén A, Bodin L. Impact of nocturnal bruxism on mercury uptake from dental amalgams. Eur J Oral Sci 1997;105:251-257.
35. Berdouses E, Vaidyanathan TK, Dastane A, Weisel C, Houpt M, Shey Z. Mercury release from dental amalgams: An in vitro study under controlled chewing and brushing in an artificial mouth. J Dent Res 1995;74:1185-1193.
36. Halbach S. Combined estimation of mercury species released from amalgam. J Dent Res 1995,74:1103-1109.
37. Halbach S. Amalgam tooth fillings and man's mercury burden. Hum Exp Toxicol 1994;13:496-501.
38. Halbach S. Estimation of mercury dose by a novel quantitation of elemental and inorganic species released from amalgam. Int Arch Occup Environ Health 1995;67: 295-300.
39. Kingman A, Albertini T, Brown LJ. Mercury concentrations in urine and whole blood associated with amalgam exposure in a US military population. J Dent Res 1998;77: 461-471.
40. Nylander M, Friberg L, Lind B. Mercury concentrations in the human brain and kidneys in relation to exposure from dental amalgam fillings. Swed Dent J 1987;11:179-187.
41. Nylander M, Friberg L, Eggleston D, Björkman L. Mercury accumulation in tissues from dental staff and controls in relation to exposure. Swed Dent J 1989;13: 235-243.
42. Hahn LJ, Kloiber R, Vimy MJ, Takahashi Y, Lorscheider FL. Dental "silver" tooth fillings: A source of mercury exposure revealed by whole-body image scan and tissue analysis. FASEB J 1989;3:2641-2646.
43. Hahn LJ, Kloiber R, Leninger RW, Vimy MJ, Lorscheider FL. Whole-body imaging of the distribution of mercury released from dental fillings into monkey tissues. FASEB J 1990;4:3256-3260.
44. Eley BM. The future of dental amalgam: A review of the literature. Part 5: Mercury in the urine, blood and body organs from amalgam fillings. Br Dent J 1997,182:413-417.
45. Boyd ND, Benediktsson H, Vimy MJ, Hooper DE, Lorscheider FL. Mercury from dental "silver" tooth fillings impairs sheep kidney function. Am J Physiol 1991;261: R1010-R1014.
46. Malvin RL, Schnermann JB, Churchill PC, Bidani AK. Mercury from dental "silver" tooth fillings [letter]. Am J Physiol 1992;262:R716-R717.
47. Eti S, Weisman R, Hoffman R, Redenberg MM. Slight renal effect of mercury from amalgam fillings. Pharmacol Toxicol 1995;76:47-49.
48. Molin M, Bergman B, Marklund SL, Schütz A, Skerfving S. Mercury, selenium, and glutathione peroxidase before and after amalgam removal in man. Acta Odontol Scand 1990;48:189-202.
49. Sandborgh-Englund G, Nygren AT, Ekstrand J, Elinder C-G. No evidence of renal toxicity from amalgam fillings. Am J Physiol 1996;271:R941-R945.
50. Herrström P, Schütz A, Raihle G, Holthuis N. Dental amalgam, low-dose exposure to mercury and urinary proteins in young Swedish men. Arch Environ Health 1995;50:103-107.
51. Naleway C, Chou H-N, Muller T, Dabney J, Roxe D, Siddiqui F. On-site screening for urinary Hg concentrations and correlation with glomerular and renal tubular function. J Public Health Dent 1991;51:12-17.
52. Langworth S, Sällsten G, Barregård L, Cynkier I, Lind M-L, Söderman E. Exposure to mercury vapor and impact on health in the dental profession in Sweden. J Dent Res 1997;76:1397-1404.
53. Eggleston DW, Nylander M. Correlation of dental amalgam with mercury in brain tissue. J Prosthet Dent 1987;58:704-707.
54. Nylander M. Mercury in pituitary glands of dentists. Lancet 1986;1:442.
55. Wenstrup D, Ehmann WD, Markesbery WR. Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains. Brain Res 1990;533:125-131.
56. Saxe SR, Wekstein MW, Kryscio RJ, et al. Alzheimer's disease, dental amalgam and mercury. J Am Dent Assoc 1999;130:191-199.
57. Leong CCW, Syed NI, Lorscheider FL. Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. Neuroreport 2001;12:733-737.
58. Bio-Probe News. Scientists connect Alzheimer's disease to mercury [online]. Available: http://www.bioprobe.com/ ReadNews.asp?article=31. Accessed March 31, 2001.
59. Pendergrass JC, Haley BE, Vimy MJ, Winfield SA, Lorscheider FL. Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: Similarity to a molecular lesion in Alzheimer diseased brain. Neurotoxicology 1997; 18:315-324.
60. Langworth S, Kölbeck K-G, Akesson A. Mercury exposure from dental fillings. II. Release and absorption. Swed Dent J 1988;12:71-72.
61. Saxe SR, Snowdon DA, Wekstein MW, et al. Dental amalgam and cognitive function in older women: Findings from the nun study. J Am Dent Assoc 1995;126: 1495-1501.
62. Huggins HA. Amalgam in motion. Dent Assist 1985; 54(3):10-13.
63. Clausen J. Mercury and multiple sclerosis. Acta Neurol Scand 1993;87:461-464.
64. McGrother CW, Dugmore C, Phillips MJ, Raymond NT, Garrick P, Baird WO. Multiple sclerosis, dental caries and fillings: A case-control study. Br Dent J 1999;187:261-264.
65. Bangsi D, Ghadirian P, Ducic S, et al. Dental amalgam and multiple sclerosis: A case-control study in Montreal, Canada. Int J Epidemiol 1998;27:667-671.
66. The NMSS Sourcebook Dentistry Website. Available: http://www.nmss.org/\Sourcebook-Dentistry.asp. Accessed: June 6, 2001.
67. Rodvall Y, Ahlbom A, Pershagen G, Nylander M, Spannare B. Dental radiography after age 25 years, amalgam fillings and tumours of the central nervous system. Oral Oncol 1998;34:265-269.
68. Siblerud RL. Health effects after dental amalgam removal. J Orthomol Med 1990;5:95-106.
69. Lichtenberg H. Elimination of symptoms by removal of dental amalgam from mercury poisoned patients, as compared with a control group of average patients. J Orthomol Med 1993;8:145-148.
70. Zamm AV. Removal of dental mercury: Often an effective treatment for the very sensitive patient. J Orthomol Med 1990;5:138-142.
71. Kidd RF. Results of dental amalgam removal and mercury detoxification using DMPS and neural therapy. Altern Ther 2000;6(4):49-55.
72. Ding G-S, Liang Y-Y. Antidotal effects of dimercaptosuccinic acid. J Appl Toxicol 1991;11:7-14.
73. Grandjean P, Guldager B, Larsen IB, Jørgensen PJ, Holmstrup P. Placebo response in environmental disease: Chelation therapy of patients with symptoms attributed to amalgam fillings. J Occup Environ Med 1997;39:707-714.
74. Sandborgh-Englund G, Dahlqvist R, Lindelöf B, Söderman E, Jonzon B, Vesterberg O. DMSA administration to patients with alleged mercury poisoning from dental amalgams: A placebo-controlled study. J Dent Res 1994;73:620-628.
75. Packer M. The placebo effect in heart failure. Am Heart J 1990;120:1579-1582.
76. Melchart D, Wühr E, Weidenhammer W, Kremers L. A multicenter survey of amalgam fillings and subjective complaints in non-selected patients in the dental practice. Eur J Oral Sci 1998;106:770-777.
77. Michel I, Norbäck D, Edling C. An epidemiologic study of the relation between symptoms of fatigue, dental amalgam and other factors. Swed Dent J 1989;13:33-38.
78. Ahlqwist M, Bengtsson C, Lapidus L. Number of amalgam fillings in relation to cardiovascular disease, diabetes, cancer and early death in Swedish women. Community Dent Oral Epidemiol 1993;21:40-44.
79. Ahlqwist M, Bengtsson C, Furunes B, Hollender L, Lapidus L. Number of amalgam tooth fillings in relation to subjectively experienced symptoms in a study of Swedish women. Community Dent Oral Epidemiol 1988;16: 227-231.
80. Strömberg R, Langworth S, Söderman E. Mercury inductions in persons with subjective symptoms alleged to dental amalgam fillings. Eur J Oral Sci 1999;107:208-214.
81. Bratel J, Haraldson T, Meding B, Yontchev E, Öhman S-C, Ottosson J-O. Potential side effects of dental amalgam restorations. I. An oral and medical investigation. Eur J Oral Sci 1997;105:234-243.
82. Bratel J, Haraldson T, Ottosson J-O. Potential side effects of dental amalgam restorations. II. No relation between mercury levels in the body and mental disorders. Eur J Oral Sci 1997;105:244-250.
83. Molin M, Marklund S, Bergman B, Bergman M, Stenman E. Plasma-selenium, glutathione peroxidase in erythrocytes and mercury in plasma in patients allegedly subject to oral galvanism. Scand J Dent Res 1987;95:328-334.
84. Herrström P, Högstedt B. Clinical study of oral galvanism: No evidence of toxic mercury exposure but anxiety disorder an important background factor. Scand J Dent Res 1993;101:232-237.
85. Huggins HA. Mercury-A factor in mental disease? Part 1. Can mercury-silver amalgams cause psychiatric symptoms? Oral Health 1983;73:42-45.
86. Lindberg NE, Lindberg E, Larsson G. Psychologic factors in the etiology of amalgam illness. Acta Odontol Scand 1994;52:219-228.
87. Björkman L, Pedersen NL, Lichtenstein P. Physical and mental health related to dental amalgam fillings in Swedish twins. Community Dent Oral Epidemiol 1996; 24:260-267.
88. Eggleston DW. Effect of dental amalgam and nickel alloys on T-lymphocytes: Preliminary report. J Prosthet Dent 1983;51:617-623.
89. Mackert JR, Leffell MS, Wagner DA, Powell BJ. Lymphocyte levels in subjects with and without amalgam restorations. J Am Dent Assoc 1991;122(3):49-53.
90. Loftenius A, Sandborgh-Englund G, Ekstrand J. Acute exposure to mercury from amalgam: No short-time effect on the peripheral blood lymphocytes in healthy individuals. J Toxicol Environ Health 1998;54:547-560.
91. Herrström P, Holmén A, Karlsson A, Raïhle G, Schütz A, Högstedt B. Immune factors, dental amalgam, and low-dose exposure to mercury in Swedish adolescents. Arch Environ Health 1994;49:160-164.
92. Herrström P, Högstedt B. Dental restorative materials and the prevalence of eczema, allergic rhino-conjunctivitis, and asthma in schoolchildren. Scand J Prim Health Care 1994;12:3-8.
93. Langworth S, Elinder C-G, Sundqvist K-G. Minor effects of low exposure to inorganic mercury on the human immune system. Scand J Work Environ Health 1993;19: 405-413.
94. Summers AO, Wireman J, Vimy MJ, et al. Mercury released from dental "silver" fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates. Antimicrob Agents Chemother 1993;37:825-834.
95. Kurtz KS. A clinician's perspective. "Compounding irresponsibility: The unpalatable triad of bad science, bad refereeing, and bad journalism." J Dent Res 1994;73: 1130-1132.
96. Shearer BG. Dental amalgam and multiple antibiotic resistance: An untested hypothesis [letter]. Antimicrob Agents Chemother 1993;37:1730.
97. Edlund C, Björkman L, Ekstrand J, Sandborgh-Englund G, Nord CE. Resistance of the normal human microflora to mercury and antimicrobials after exposure to mercury from dental amalgam fillings. Clin Infect Dis 1996;22: 944-950.
98. Österblad M, Leistevuo J, Leistevuo T, et al. Antimicrobial and mercury resistance in aerobic gram-negative bacilli in fecal flora among persons with and without dental amalgam fillings. Antimicrob Agents Chemother 1995;39: 2499-2502.
99. Leistevuo J, Järvinen H, Österblad M, Leistevuo T, Huovinen P, Tenovuo J. Resistance to mercury and antimicrobial agents in Streptococcus mutans isolates from human subjects in relation to exposure to dental amalgam fillings. Antimicrob Agents Chemother 2000;44:456-457.
100. Sikorski R, Juszkiewicz T, Paszkowski T, Szprengier-Juszkiewicz T. Women in dental surgeries: Reproductive hazards in occupational exposure to metallic mercury. Int Arch Occup Environ Health 1987;59:551-557.
101. Larsson KS. Teratological aspects of dental amalgam. Adv Dent Res 1992;6:114-119.
102. Ericson A, Källén B. Pregnancy outcome in women working as dentists, dental assistants or dental technicians. Int Arch Occup Environ Health 1989;61:329-333.
103. Brodsky JB, Cohen EN, Whitcher C, Brown BW, Wu ML. Occupational exposure to mercury in dentistry and pregnancy outcome. J Am Dent Assoc 1985;111:779-780.
104. Rowland AS, Baird DD, Weinberg CR, Shore DL, Shy CM, Wilcox AJ. The effect of occupational exposure to mercury vapour on the fertility of female dental assistants. Occup Environ Med 1994;51:28-34.
105. Sunby J, Dahl JE. Are women in the workplace less fertile than women who are not employed? J Women's Health 1994;3:65-72.
106. Dahl JE, Sunby J, Hensten-Pettersen A, Jacobsen N. Dental workplace exposure and effect on fertility. Scand J Work Environ Health 1999;25:285-290.
107. Heidam LZ. Spontaneous abortions among dental assistants, factory workers, painters, and gardening workers: A follow-up study. J Epidemiol Community Health 1984;38: 149-155.
108. Warfvinge K. Mercury exposure of a female dentist before pregnancy. Br Dent J 1995;178:149-152.
109. Thorp JM, Boyette DD, Watson WJ, Cefalo RC. Elemental mercury exposure in early pregnancy. Obstet Gynecol 1992;79:874-876.
110. Schuurs AHB. Reproductive toxicity of occupational mercury. A review of the literature. J Dent 1999;27:249-256.
111. Domb B. Give Dr Dickerson credit [letter]. Dent Econ 1999;89(7):17.
112. Martin MD, Naleway C, Chou H-N. Factors contributing to mercury exposure in dentists. J Am Dent Assoc 1995;126:1502-1511.
113. Shapiro IM, Cornblath DR, Sumner AJ, et al. Neurophysiological and neuropsychological function in mercury-exposed dentists. Lancet 1982;1:1147-1150.
114. Ngim CH, Foo SC, Boey KW, Jeyaratnam J. Chronic neurobehavioural effects of elemental mercury in dentists. Br J Ind Med 1992;49:782-790.
115. Eley BM. The future of dental amalgam: A review of the literature. Part 2. Mercury exposure in dental practice. Br Dent J 1997;182:293-297.
116. o among dentists. Neurotoxicol Teratol 1995;17: 161-168.
117. o: New distinctions between recent exposure and Hg body burden. FASEB J 1998;12:971-980.
118. Jankovic J, Brin M. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-1194.
119. Tan E-K, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc 2000;131:211-216.
120. Geurtsen W, Lehmann F, Spahl W, Leyhausen G. Cytotoxicity of 35 dental resin composite monomers/additives in permanent 3T3 and three human primary fibroblast cultures. J Biomed Mater Res 1998;41:474-480.
121. Lygre H, Hol PJ, Solheim E, Moe G. Organic leachables from polymer-based dental filling materials. Eur J Oral Sci 1999;107:378-383.
122. Leyhausen G, Lehmann F, Geurtsen W. Cytocompatibility of 38 composite monomers/additives in human oral primary cell cultures [abstract 2945]. J Dent Res 1997;76 (special issue):382.
123. Arenholt-Bindslev D, Ebbehöj E, Hörsted-Bindslev P. Cytotoxicity of conditioners and bonding agents [abstract 111]. J Dent Res 1994;73(special issue):952.
124. Bouillaguet S, Wataha JC, Hanks CT, Ciucchi B, Holz J. In vitro cytotoxicity and dentin permeabililty of HEMA. J Endod 1996;22:244-248.
125. Wataha JC, Rueggeberg FA, Lapp CA, et al. In vitro cytotoxicity of resin-containing restorative materials after aging in artificial saliva. Clin Oral Invest 1999;3:144-149.
126. 6 on rat dental pulp cells. Dent Mater J 1999;18:271-277.
127. Sletten GBG, Dahl JE. Cytotoxic effects of extracts of compomers. Acta Odontol Scan 1999;57:316-322.
128. Hikage S, Sato A, Suzuki S, Cox CF, Sakaguchi K. Cytotoxicity of dental resin monomers in the presence of S9 mix enzymes. Dent Mater J 1999;18:76-86.
129. Costa CAS, Vaerten MA, Edwards CA, Hanks CT. Cytotoxic effects of current dental adhesive systems on immortalized odontoblast cell line MDPC-23. Dent Mater 1999;15:434-441
130. Costa CAS, Teixeira HM, Nascimento ABL, Hebling J. Biocompatibility of two current adhesive resins. J Endodon 2000;26:512-516.
131. Imazato S, Tarumi H, Ebi N, Ebisu S. Cytotoxic effects of composite restorations employing self-etching primers or experimental antibacterial primers. J Dent 2000;28:61-67.
132. Geurtsen W. Biocompatibility of resin-modified filling materials. Crit Rev Oral Biol Med 2000;11:333-355.
133. Schweikl H, Schmalz G. Glutaraldehyde-containing dentin bonding agents are mutagens in mammalian cells in vitro. J Biomed Mater Res 1997;36:284-288.
134. Schweikl H, Schmalz G, Göttke C. Mutagenic activity of various dentine bonding agents. Biomater 1996;17: 1451-1456.
135. Schweikl H, Schmalz G, Bey B. Mutagenicity of dentin bonding agents. J Biomed Mater Res 1994;28:1061-1067.
136. Schweikl H, Schmalz G, Rackebrandt K. Mutagenic activity of resin components in mammalian cells [abstract 2946]. J Dent Res 1997;76(special issue):382.
137. Wataha JC, Hanks CT, Strawn SE, Fat JC. Cytotoxicity of components of resins and other dental resotrative materials. J Oral Rehabil 1994;21:453-462.
138. Jontell M, Hanks CT, Bratel J, Bergenholtz G. Effects of unpolymerized resin components on the function of accessory cells derived from the rat incisor pulp. J Dent Res 1995;74:1162-1167.
139. Hanks CT, Strawn SE, Wataha JC, Craig RG. Cytotoxic effects of resin components on cultured mammalian fibroblasts. J Dent Res 1991;70:1450-1455.
140. Caughman WF, Caughman GB, Dominy WT, Schuster GS. Glass ionomer and composite resin cements: Effects on oral cells. J Prosthet Dent 1990;63:513-521.
141. Al-Nazhan S, Sapounas G, Spångberg L. In vitro study of the toxicity of a composite resin, silver amalgam, and Cavit. J Endod 1988;14:236-238.
142. Rakich DR, Wataha JC, Lefebvre CA, Weller RN. Effects of dentin bonding agents on macrophage mitochondrial activity. J Endod 1998;24:528-533.
143. Hansasuta C, Neiders ME, Aguirre A, Cohen RE. Cellular inflammatory responses to direct restorative composite resins. J Prosthet Dent 1993;69:611-616.
144. Blomgren J, Axéll T, Sandahl O, Jontell M. Adverse reactions in the oral mucosa associated with anterior composite restorations. J Oral Pathol Med 1996;25:311-313.
145. Lind PO. Oral lichenoid reactions related to composite restorations: Preliminary report. Acta Odontol Scand 1988;46:63-65.
146. Nathanson D, Lockhart P. Delayed extraoral hypersensitivity to composite material. Oral Surg Oral Med Oral Pathol 1979;47:329-333.
147. Carmichael AJ, Gibson JJ, Walls AWG. Allergic contact dermatitis to bisphenol-A-glycidyldimethacrylate (BIS-GMA) dental resin associated with sensitivity to epoxy resin. Br Dent J 1997;183:297-298.
148. Hensten-Pettersen A. Replacement of restorations based on material allergies. In: Anusavice KJ (ed). Quality Evaluation of Dental Restorations: Criteria for Placement and Replacement. Chicago: Quintessence, 1987:357-371.
149. Örtengren U, Andreasson H, Karlsson S, Meding B, barregård L. Prevalence of self-reported hand eczema and skin symptoms associated with dental materials among Swedish dentists. Eur J Oral Sci 1999;107:496-505.
150. Munksgaard EC. Permeability of protective gloves to (di)methacrylates in resinous dental materials. Scand J Dent Res 1992;100:189-192.
151. Hansel C, Leyhausen G, Mai UEH, Geurtsen W. Effects of various resin composite (co)monomers and extracts on two caries-associated micro-organisms in vitro. J Dent Res 1998;77:60-67.
152. Øysæd H, Ruyter IE, Sjovik Kleven IJ. Release of formaldehyde from dental composites. J Dent Res 1988;67:1289-1294.
153. Koch MJ, Alves da Rocha M, Stein G, Mayer T, Staehle HJ. Formaldehyde release from sealant materials [abstract 1533]. J Dent Res 1994;73(special issue):293.
154. Ruyter IE, Sjovik Kleven I. Formaldehyde release from light-cured glass ionomer restorative materials [abstract 1534]. J Dent Res 1994;73(special issue):293.
155. Larsson KS. Potential teratogenic and carcinogenic effects of dental materials. Int Dent J 1991;41:206-211.
156. Wahl MJ. Misleading your patients [letter]. J Am Dent Assoc 1996;127:422.
157. Ruyter IE. Physical and chemical aspects related to substances released from polymer materials in an aqueous environment. Adv Dent Res 1995;9:344-347.
158. Slaga TJ, Klein-Santo AJP, Triplett LL, Yotti LP, Trosko JE. Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science 1981;213:1023-1025.
159. Bonfil RD, Momiki S, Conti CJ, Klein-Szanto AJP. Benzoyl peroxide enhances the invasive ability of a mouse epidermal carcinoma cell line. Int J Cancer 1989;44: 165-169.
160. O'Connell JF, Klein-Szanto AJP, DiGiovanni DM, Fries JW, Slaga TJ. Enhanced malignant progression of mouse skin tumors by the free-radical generator benzoyl peroxide. Cancer Res 1986;46:2863-2865.
161. Arenholt-Bindslev D. Environmental aspects of dental filling materials. Eur J Oral Sci 1998;106:713-720.
162. Mackert JR Jr. Side-effects of dental ceramics. Adv Dent Res 1992;6:90-93.
163. Petros H, MacMillan AL. Allergic contact sensitivity to gold with unusual features. Br J Dermatol 1973;88: 505-508.
164. Dowden WE, Langeland K. An evaluation and comparison of the pulpal response to gold foil and indium alloy. J Prosthet Dent 1983;50:497-504.
165. Schuster GS, Lefebvre CA, Wataha JC, White SN. Biocompatibility of posterior restorative materials. CDA J 1996;24(9):17-31.
166. Söderholm K-J, Mariotti A. Bis-GMA-based resins in dentistry: Are they safe? J Am Dent Assoc 1999;130:201-209.
167. Stanley HR. Local and systemic responses to dental composites and glass ionomers. Adv Dent Res 1992;6:55-64.
168. Douglass C. Alternatives to dental amalgam: What do we know about their safety? Oral Care Rep 1999;9(3):1-3.
169. Geurtsen W. Substances released from dental resin composites and glass ionomer cements. Eur J Oral Sci 1998; 106:687-695.
170. Schmalz G. The biocompatibility of non-amalgam dental filling materials. Eur J Oral Sci 1998;106:696-706.